Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Krawiec

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Artificial Intelligence in Medicine|April 18, 2000
Evolutionary weighting of image features for diagnosing of CNS tumorsM Komosiński, K Krawiec
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|September 11, 1999
Intelligent decision support in pathomorphologyJ Jelonek, K Krawiec, R Słowiński, et al.
Biochemical and Biophysical Research Communications|November 2, 1995
Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinaseK Krawiec, B Kierdaszuk, S Eriksson, et al.
Acta Biochimica Polonica|August 13, 1998
Unusual nucleoside triphosphate donors for nucleoside kinases: 3'-deoxyadenosine-2'-triphosphate and 2'-deoxyadenosine-3'-triphosphateK Krawiec, B Kierdaszuk, E N Kalinichenko, et al.
Breast Cancer Research and Treatment|March 17, 2011
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort studyC Eriksen, J Frisell, M Wickman, et al.
Nucleosides & Nucleotides|September 9, 1999
Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analoguesB Kierdaszuk, K Krawiec, Z Kazimierczuk, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2)B Kierdaszuk, K Krawiec, Z Kazimierczuk, et al.
Journal of Veterinary Internal Medicine|April 14, 2020
Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel diseaseJuan J Estruch, Derren Barken, Nicole Bennett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Artificial Intelligence in Medicine|April 18, 2000
Evolutionary weighting of image features for diagnosing of CNS tumorsM Komosiński, K Krawiec
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|September 11, 1999
Intelligent decision support in pathomorphologyJ Jelonek, K Krawiec, R Słowiński, et al.
Biochemical and Biophysical Research Communications|November 2, 1995
Nucleoside triphosphate donors for nucleoside kinases: donor properties of UTP with human deoxycytidine kinaseK Krawiec, B Kierdaszuk, S Eriksson, et al.
Acta Biochimica Polonica|August 13, 1998
Unusual nucleoside triphosphate donors for nucleoside kinases: 3'-deoxyadenosine-2'-triphosphate and 2'-deoxyadenosine-3'-triphosphateK Krawiec, B Kierdaszuk, E N Kalinichenko, et al.
Breast Cancer Research and Treatment|March 17, 2011
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort studyC Eriksen, J Frisell, M Wickman, et al.
Nucleosides & Nucleotides|September 9, 1999
Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analoguesB Kierdaszuk, K Krawiec, Z Kazimierczuk, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2)B Kierdaszuk, K Krawiec, Z Kazimierczuk, et al.
Journal of Veterinary Internal Medicine|April 14, 2020
Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel diseaseJuan J Estruch, Derren Barken, Nicole Bennett, et al.
Pageof 1